Nebenwirkungen · Cibinqo
Cibinqo 50 mg film-coated tablets Cibinqo 100 mg film-coated tablets Cibinqo 200 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 11–12
HOS-147576 · Präparat HOS-099686
11 Table 2. Adverse reactions System organ class Very common Common Uncommon Infections and infestations Herpes simplexa Pneumonia Herpes zosterb Blood and lymphatic system Thrombocytopenia disorders Lymphopenia Neutropeniac Metabolism and nutrition Hyperlipidaemiad disorders Nervous system disorders Headache Dizziness Vascular disorders Venous thromboembolisme Gastrointestinal disorders Nausea Vomiting Abdominal pain upper Skin and subcutaneous Acne tissue disorders Investigations Creatine phosphokinase increased ˃ 5 × ULNf a. Herpes simplex includes oral herpes, ophthalmic herpes simplex, genital herpes, and herpes dermatitis. b. Herpes zoster includes ophthalmic herpes zoster. c. Neutropenia includes neutrophil count decreased and granulocytopenia. d. Hyperlipidaemia includes dyslipidaemia and hypercholesterolaemia. e. Venous thromboembolism includes pulmonary embolism and deep vein thrombosis. f. Includes changes detected during laboratory monitoring (see text below).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-16T15:51:00Z · SHA-256 bdf6a4ed1027bc748659bcb0a96655dbad2dd1f8fd77f49e5ad43eff208cc7ff · Passage 31647f441a8c0a002bddc72cfd522b59793895afca2772fae744c09a7ba70811 · Zeichen 1508–3623 im Abschnitt